Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes
NCT00379652 · View on ClinicalTrials.gov ↗
Study Summary
Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian population. This study will attempt to identify factors that contribute to racial and ethnic differences in hypertension and diabetes care among minority patients of community health centers (CHCs). This information will be used to design and implement programs to improve quality of care in these communities.
Conditions Studied
Interventions
- BEHAVIORAL Medical Practice Improvement
- BEHAVIORAL Patient Education and Support
- OTHER Combination Intervention to Include Medical Practice Improvement and Patient Education and Support
Study Locations (2)
Massachusetts
- Harvard Medical School — Boston
- Center for Community Health Education, Research, and Service — Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,204 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00379652
The ClinicalTrials.gov registry entry for NCT00379652 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Medical School (HMS and HSDM), which has 71 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions — of which Medical Practice Improvement is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00379652 reports 2 study locations spanning 1 distinct geographic area — top geographies include Massachusetts. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00379652 about?
NCT00379652 is a clinical study titled "Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes". Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian population. This study will attempt to identify factors that contribute to racial and ethnic differences in hypertension...
What is the current status of trial NCT00379652?
This trial is currently completed. It is a NA study. The enrollment target is 1,204 participants. The study started on 2009-10. Estimated completion is 2010-05.
What conditions does trial NCT00379652 study?
This clinical trial studies the following conditions: Hypertension, Diabetes Mellitis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00379652?
The interventions under investigation include: Medical Practice Improvement (BEHAVIORAL), Patient Education and Support (BEHAVIORAL), Combination Intervention to Include Medical Practice Improvement and Patient Education and Support (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00379652?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 71 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00379652 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.